FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jan Skrha

Research Profile

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Juraj Gáll; Eva Sedláčková; Jan Skrha; Karina Verébová; Richard Buchal; Jan Pláteník
Induction of the mitochondrial permeability transition (MPT) by micromolar iron: liberation of calcium is more important than NAD(P)H oxidation.
Tomas Stulc; Richard Ceska; Iuri Marinov; Jan Skrha
The effect of simvastatin and fenofibrate on the expression of leukocyte adhesion molecules and lipopolysaccharide receptor CD14 in type 2 diabetes mellitus.
Jana Vrbíková; Michael Fanta; J Marek; Terezie Pelikánová; Jan Skrha
[A recommended approach to evaluate cardiovascular risk and to prevent cardiovascular diseases and type 2 diabetes mellitus in women with polycystic ovary syndrome].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jan Skrha (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Juraj Gáll; Eva Sedláčková; Jan Skrha; Karina Verébová; Richard Buchal; Jan Pláteník
Induction of the mitochondrial permeability transition (MPT) by micromolar iron: liberation of calcium is more important than NAD(P)H oxidation.
Biochimica et biophysica acta 2012;1817(9):1537-49.
2012: Tomas Stulc; Richard Ceska; Iuri Marinov; Jan Skrha
The effect of simvastatin and fenofibrate on the expression of leukocyte adhesion molecules and lipopolysaccharide receptor CD14 in type 2 diabetes mellitus.
Neuro endocrinology letters 2012;33 Suppl 2():73-7.
2012: Jana Vrbíková; Michael Fanta; J Marek; Terezie Pelikánová; Jan Skrha
[A recommended approach to evaluate cardiovascular risk and to prevent cardiovascular diseases and type 2 diabetes mellitus in women with polycystic ovary syndrome].
Vnitr̆ní lékar̆ství 2012;58(1):56-7.
2012: Eva Horová; Jan Kvasnicka; Jirí Mazoch; Jan Skrha; Jan Soupal; Jiřina Hiigertová; Martin Prázný
Acute hyperglycemia does not impair microvascular reactivity and endothelial function during hyperinsulinemic isoglycemic and hyperglycemic clamp in type 1 diabetic patients.
Experimental diabetes research 2012;2012():851487.
2010: Jan Skrha
[Type 2 diabetes mellitus as a subclinical inflammation].
Casopís lékar̆ů c̆eských 2010;149(6):277-81.
2010: Jan Skrha; Jirina Hilgertová; M Jarolímková; M Kunešová; Martin Hill
Meal test for glucose-dependent insulinotropic peptide (GIP) in obese and type 2 diabetic patients.
Physiological research / Academia Scientiarum Bohemoslovaca 2010;59(5):749-55.
2010: V Danzig; B Míková; P Kuchynka; H Benáková; Tomáš Zima; O Kittnar; Jan Skrha; A Linhart; Marta Kalousová
Levels of circulating biomarkers at rest and after exercise in coronary artery disease patients.
Physiological research / Academia Scientiarum Bohemoslovaca 2010;59(3):385-92.
2009: Martin Prázný; Zdislava Kasalová; Jirí Mazoch; Jan Kvasnicka; Jan Skrha
Microvascular Reactivity and Endothelial Function in Type 2 Diabetic Patients with Hyperlipidemia Treated with Simvastatin: 3-year Follow-up.
Prague medical report 2009;110(4):290-300.
2009: Jan Skrha
Effect of caloric restriction on oxidative markers.
Advances in clinical chemistry 2009;47():223-47.
2008: Michael H Shanik; Yuping Xu; Jan Skrha; Rachel Dankner; Yehiel Zick; Jesse Roth
Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?
Diabetes care 2008;31 Suppl 2():S262-8.
2008: Milan Flekac; Jan Skrha; Jirina Hilgertova; Zdena Lacinova; Marcela Jarolimkova
Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus.
BMC medical genetics 2008;9():30.
2008: M Flekac; Jan Skrha; Katerina Zídková; Zdena Lacinová; Jirina Hilgertová
Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus.
Physiological research / Academia Scientiarum Bohemoslovaca 2008;57(5):717-26.
2008: Martin Prázný; Jana Jezková; E Horová; V Lazárová; Václav Hána; J Kvasnicka; L Pecen; Josef Marek; Jan Skrha; Michal Krsek
Impaired microvascular reactivity and endothelial function in patients with Cushing's syndrome: influence of arterial hypertension.
Physiological research / Academia Scientiarum Bohemoslovaca 2008;57(1):13-22.
2007: Jan Skrha; Martin Prázný; Jirina Hilgertová; Jan Kvasnicka; Marta Kalousová; Tomáš Zima
Oxidative stress and endothelium influenced by metformin in type 2 diabetes mellitus.
European journal of clinical pharmacology 2007;63(12):1107-14.
2007: Daniela Pelclová; Martin Prázny; Jan Skrha; Zdenka Fenclová; Marta Kalousová; Pavel Urban; Tomás Navrátil; Zdenka Senholdová; Zdenek Smerhovsky
2,3,7,8-TCDD exposure, endothelial dysfunction and impaired microvascular reactivity.
Human & experimental toxicology 2007;26(9):705-13.
2007: K Anderlová; R Dolezalová; J Housová; L Bosanská; D Haluzíková; Jaromir Kremen; Jan Skrha; Martin Haluzík
Influence of PPAR-alpha agonist fenofibrate on insulin sensitivity and selected adipose tissue-derived hormones in obese women with type 2 diabetes.
Physiological research / Academia Scientiarum Bohemoslovaca 2007;56(5):579-86.
2006: Zdislava Kasalová; Martin Prázný; Jan Skrha
Relationship between peripheral diabetic neuropathy and microvascular reactivity in patients with type 1 and type 2 diabetes mellitus -- neuropathy and microcirculation in diabetes.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2006;114(2):52-7.
2006: Ondrej Petrák; Jirí Widimský; Tomás Zelinka; Jan Kvasnicka; Branislav Strauch; Robert Holaj; Tomas Stulc; Tomás Kvasnicka; J Bílková; Jan Skrha
Biochemical markers of endothelial dysfunction in patients with endocrine and essential hypertension.
Physiological research / Academia Scientiarum Bohemoslovaca 2006;55(6):597-602.
2006: Marie Kunesová; R Braunerová; P Hlavatý; Eva Tvrzická; Barbora Stanková; Jan Skrha; Jirina Hilgertová; Martin Hill; Jan Kopecký; Martin Wagenknecht; Vojtech Hainer; M Matoulek; Jana Parízková; Ales Zák; Stepan Svacina
The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women.
Physiological research / Academia Scientiarum Bohemoslovaca 2006;55(1):63-72.
2005: Jana Vrbíková; Karel Vondra; David Cibula; Katerina Dvoráková; Sona Stanická; Daniela Srámková; Gustav Sindelka; Martin Hill; Bela Bendlová; Jan Skrha
Metabolic syndrome in young Czech women with polycystic ovary syndrome.
Human reproduction (Oxford, England) 2005;20(12):3328-32.
2005: Marta Kalousová; Tomáš Zima; Vladimír Tesar; Sylvie Dusilová-Sulková; Jan Skrha
Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background.
Mutation research 2005;579(1-2):37-46.
2005: John Dormandy; Bernard Charbonnel; David J A Eckland; Erland Erdmann; Massimo Massi Benedetti; Ian K Moules; Allan M Skene; Meng Tan; Pierre J Lefèbvre; Gordon D Murray; Eberhard Standl; Robert G Wilcox; Lars Wilhelmsen; John Betteridge; Kåre Birkeland; Alain Golay; Robert J Heine; László Korányi; Markku Laakso; Marián Mokán; Antanas Norkus; Valdis Pirags; Toomas Podar; André Scheen; Werner A Scherbaum; Guntram Schernthaner; Ole Schmitz; Jan Skrha; Ulf Smith; Jan Taton
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
Lancet 2005;366(9493):1279-89.
2005: Jan Skrha; Anu Ambos
Can the atherosclerosis prevention targets be achieved in type 2 diabetes?
Diabetes research and clinical practice 2005;68 Suppl1():S48-51.
2005: Zvonko Milicevic; Itamar Raz; Krzysztof Strojek; Jan Skrha; Meng Tan; John W Wyatt; Scott D Beattie; David C Robbins
Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with Type 2 diabetes mellitus (HEART2D) Study design.
Journal of diabetes and its complications 2005;19(2):80-7.
2005: Martin Prázný; Jan Skrha; Zdenka Límanová; Zdislava Vanícková; Jirina Hilgertová; J Prázná; Marcela Jaresová; Ilja Stríz
Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control.
Physiological research / Academia Scientiarum Bohemoslovaca 2005;54(1):41-8.
2005: Jan Skrha; Marie Kunesová; Jirina Hilgertová; Hana Weiserová; J Krízová; Eva Kotrlíková
Short-term very low calorie diet reduces oxidative stress in obese type 2 diabetic patients.
Physiological research / Academia Scientiarum Bohemoslovaca 2005;54(1):33-9.
2005: David Cibula; Michael Fanta; Jana Vrbikova; S Stanicka; Katerina Dvorakova; Martin Hill; Jan Skrha; Jaroslav Zivny; J Skrenkova
The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients.
Human reproduction (Oxford, England) 2005;20(1):180-4.
2004: Jan Skrha; Tomas Stulc; Jirina Hilgertová; Hana Weiserová; Jan Kvasnicka; Richard Ceska
Effect of simvastatin and fenofibrate on endothelium in Type 2 diabetes.
European journal of pharmacology 2004;493(1-3):183-9.
2004: Jana Vrbíková; David Cibula; Katerina Dvoráková; Sona Stanická; Gustav Sindelka; Martin Hill; Michael Fanta; Karel Vondra; Jan Skrha
Insulin sensitivity in women with polycystic ovary syndrome.
The Journal of clinical endocrinology and metabolism 2004;89(6):2942-5.
2004: Jan Skrha
[Endocrine system of the gastrointestinal tract. Pathophysiology with a clinical view].
Vnitr̆ní lékar̆ství 2004;50(5):392-8.
2004: Josef V Silha; Michal Krsek; Jan Skrha; Petr Sucharda; Hoa Nguyen; Liam J Murphy
Plasma resistin, leptin and adiponectin levels in non-diabetic and diabetic obese subjects.
Diabetic medicine : a journal of the British Diabetic Association 2004;21(5):497-9.
2004: Milan Meloun; Martin Hill; Jirí Militký; Jana Vrbíková; Sona Stanická; Jan Skrha
New methodology of influential point detection in regression model building for the prediction of metabolic clearance rate of glucose.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2004;42(3):311-22.
2004: Jan Skrha; Tomas Haas; Gustav Sindelka; Martin Prázný; Jirí Widimský; David Cibula; Stepan Svacina
Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders.
The Journal of clinical endocrinology and metabolism 2004;89(1):135-41.
2003: Jan Skrha
[Pathogenesis of insulin resistance].
Vnitr̆ní lékar̆ství 2003;49(12):894-9.
2003: Mogher Khamaisi; Isaiah D Wexler; Jan Skrha; Krzysztof Strojek; Itamar Raz; Zvonko Milicevic
Cardiovascular disease in type 2 diabetics: epidemiology, risk factors and therapeutic modalities.
The Israel Medical Association journal : IMAJ 2003;5(11):801-6.
2003: Josef V Silha; Michal Krsek; Jan Skrha; Petr Sucharda; Hoa Nguyen; Liam J Murphy
Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance.
European journal of endocrinology / European Federation of Endocrine Societies 2003;149(4):331-5.
2003: Michal Krsek; Martin Prázný; Jan Skrha; Vlasta Justová; Zdena Lacinová; Tomas Haas
[Microvascular reactivity in type 2 diabetes mellitus and its relation to IGF-I and its binding proteins].
Vnitr̆ní lékar̆ství 2003;49(7):535-40.
2003: Jan Skrha
[Pathophysiology solves key questions in the therapy of type 2 diabetes mellitus].
Vnitr̆ní lékar̆ství 2003;49(4):334-8.
2003: Jan Skrha; Martin Prázný; Jirina Hilgertová; Hana Weiserová
Serum alpha-tocopherol and ascorbic acid concentrations in Type 1 and Type 2 diabetic patients with and without angiopathy.
Clinica chimica acta; international journal of clinical chemistry 2003;329(1-2):103-8.
2003: PD Broulík; Martin Haluzík; Jan Skrha
The influence of nitric oxide synthase inhibitor L-NAME on bones of male rats with streptozotocin-induced diabetes.
Physiological research / Academia Scientiarum Bohemoslovaca 2003;52(6):729-34.
2003: Branislav Strauch; Jirí Widimský; Gustav Sindelka; Jan Skrha
Does the treatment of primary hyperaldosteronism influence glucose tolerance?
Physiological research / Academia Scientiarum Bohemoslovaca 2003;52(4):503-6.
2003: Tomas Stulc; Zdislava Kasalová; Martin Prázný; Michal Vrablík; Jan Skrha; Richard Ceska
Microvascular reactivity in patients with hypercholesterolemia: effect of lipid lowering treatment.
Physiological research / Academia Scientiarum Bohemoslovaca 2003;52(4):439-45.
2003: Michal Krsek; Jan Skrha; Petr Sucharda; Vlasta Justová; Zdena Lacinová
[Changes in IGF-I levels and its binding proteins in diabetes mellitus and obesity].
Casopís lékar̆ů c̆eských 2003;142(4):216-9.
2002: Gustav Sindelka; Jan Skrha; David Cibula; Martin Prázný
[Effect of insulin in polycystic ovary syndrome].
Casopís lékar̆ů c̆eských 2002;141(24):769-72.
2002: Jan Skrha
[Biochemical changes in pregnant diabetics].
Vnitr̆ní lékar̆ství 2002;48(12):1103-6.
2002: David Cibula; Jan Skrha; Martin Hill; Michael Fanta; Lucie Haaková; J VrbIková; Jaroslav Zivný
Prediction of insulin sensitivity in nonobese women with polycystic ovary syndrome.
The Journal of clinical endocrinology and metabolism 2002;87(12):5821-5.
2002: Vojtech Melenovsky; Jan Malik; Dan Wichterle; Jan Simek; Alexandra Pisarikova; Jan Skrha; Rudolf Poledne; Petr Stavek; Richard Ceska
Comparison of the effects of atorvastatin or fenofibrate on nonlipid biochemical risk factors and the LDL particle size in subjects with combined hyperlipidemia.
American heart journal 2002;144(4):E6.
2002: Václav Hána; Martin Prázný; Josef Marek; Jan Skrha; Vlasta Justová
Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement.
European journal of endocrinology / European Federation of Endocrine Societies 2002;147(3):333-7.
2002: Jan Skrha
[Hypoglycemia, an acute complication or a syndrome?] ].
Vnitr̆ní lékar̆ství 2002;48(6):479-82.
2002: Giovanni Gambaro; Ida Kinalska; Adrian Oksa; Peter Pont'uch; Miluse Hertlová; Jindrich Olsovsky; Jacek Manitius; Domenico Fedele; Stanislaw Czekalski; Jindriska Perusicová; Jan Skrha; Jan Taton; Wladyslaw Grzeszczak; Gaetano Crepaldi
Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial.
Journal of the American Society of Nephrology : JASN 2002;13(6):1615-25.
2002: Michal Krsek; Martin Prázný; Josef Marek; Jan Skrha; Vlasta Justová; Zdena Lacinová
The relationship between serum levels of insulin-like growth factor-I and its binding proteins and microvascular function in acromegalic patients.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2002;12(1):54-9.
2002: Marta Kalousová; Jan Skrha; Tomáš Zima
Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus.
Physiological research / Academia Scientiarum Bohemoslovaca 2002;51(6):597-604.
2002: Michal Krsek; Martin Prázný; Jan Skrha; Vlasta Justová; Zdena Lacinová; Tomas Haas
The relationship between the IGF-I system and its binding proteins and microvascular reactivity in Type 1 diabetes mellitus.
Physiological research / Academia Scientiarum Bohemoslovaca 2002;51(4):379-85.
2002: Jan Skrha; A Smahelová; M Andĕl; M Vrtovec; J Subić; A Kreze; J Vozar; M Korecová; V de Verga; J Wyatt; S Metcalfe; S Ristić
Insulin lispro improves postprandial glucose control in patients with diabetes mellitus.
Sborník lékar̆ský 2002;103(1):15-21.
2002: Gustav Sindelka; Jan Skrha; Martin Prázný; Tomas Haas
Association of obesity, diabetes, serum lipids and blood pressure regulates insulin action.
Physiological research / Academia Scientiarum Bohemoslovaca 2002;51(1):85-91.
2002: M Haluzík; Gustav Sindelka; Jirí Widimský; Martin Prázný; Tomás Zelinka; Jan Skrha
Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity.
Journal of human hypertension 2002;16(1):41-5.
2002: David Cibula; Gustav Sindelka; Martin Hill; Michael Fanta; Jan Skrha; Jaroslav Zivny
Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin.
Human reproduction (Oxford, England) 2002;17(1):76-82.
2001: Jan Skrha; Martin Prázný; Tomas Haas; Jan Kvasnicka; Bohdana Kalvodová
Comparison of laser-Doppler flowmetry with biochemical indicators of endothelial dysfunction related to early microangiopathy in Type 1 diabetic patients.
Journal of diabetes and its complications 2001;15(5):234-40.
2001: Gustav Sindelka; David Cibula; Michael Fanta; Zdislava Kasalová; Vlasta Justová; Zdena Lacinová; Jan Skrha
[Can hormonal contraceptives affect plasma levels of IGF-1 and IGFBP-1 in slim women with polycystic ovary syndrome?].
Casopís lékar̆ů c̆eských 2001;140(15):469-72.
2001: Jan Skrha; Martin Prázný; Jan Kvasnicka; Bohdana Kalvodová
[Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy].
Casopís lékar̆ů c̆eských 2001;140(12):370-4.
2001: Michal Krsek; Martin Prázný; Jan Skrha; Vlasta Justová; Zdena Lacinová
[IGFBP-1 and its protective role in the pathogenesis of microangiopathy in type 1 diabetes mellitus].
Casopís lékar̆ů c̆eských 2001;140(8):234-7.
2001: Gustav Sindelka; Jirí Widimský; Martin Prázný; Zdislava Kasalová; Jan Skrha
[Effect of insulin in hypertension with high and low levels of renin].
Casopís lékar̆ů c̆eských 2001;140(7):205-8.
2001: J Sváb; M Pesková; L Krusina; Jan Skrha; Gustav Sindelka
[Personal experience with surgical treatment of insulinoma].
Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti 2001;80(2):77-81.
2001: Jirí Widimský; Branislav Strauch; Gustav Sindelka; Jan Skrha
Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus?
Physiological research / Academia Scientiarum Bohemoslovaca 2001;50(6):603-7.
2000: Martin Prázný; Jan Skrha
[Microcirculation in the skin of the upper extremities in type 1 diabetics using the laser doppler method].
Casopís lékar̆ů c̆eských 2000;139(10):309-12.
2000: Jirí Widimský; Gustav Sindelka; Tomas Haas; Martin Prázný; Jirina Hilgertová; Jan Skrha
Impaired insulin action in primary hyperaldosteronism.
Physiological research / Academia Scientiarum Bohemoslovaca 2000;49(2):241-4.
2000: Gustav Sindelka; Jirí Widimský; Tomas Haas; Martin Prázný; Jirina Hilgertová; Jan Skrha
Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2000;108(1):21-5.
1999: Martin Prázný; Jan Skrha; Jirina Hilgertová
Plasma malondialdehyde and obesity: is there a relationship?
Clinical chemistry and laboratory medicine : CCLM / FESCC 1999;37(11-12):1129-30.
1999: J Kábrt; M Dvorák; Jan Skrha; Gustav Sindelka
[Diagnosis and treatment of pancreatic islet cell tumors producing vasoactive intestinal polypeptide (VIPoma)].
Vnitr̆ní lékar̆ství 1999;45(10):606-9.
1999: Gustav Sindelka; Jan Skrha; Martin Prázný; Jirina Hilgertová
[The effect of body weight on insulin activity].
Vnitr̆ní lékar̆ství 1999;45(9):540-4.
1999: Martin Prázný; Jan Skrha
[Autoantibodies in the pathogenesis and diagnosis of insulin-dependent diabetes mellitus].
Casopís lékar̆ů c̆eských 1999;138(9):268-71.
1999: Jan Skrha; Gustav Sindelka; Jan Kvasnicka; Jirina Hilgertová
Insulin action and fibrinolysis influenced by vitamin E in obese Type 2 diabetes mellitus.
Diabetes research and clinical practice 1999;44(1):27-33.
1999: Jan Skrha; Jirina Hilgertová
Relationship of serum N-acetyl-beta-glucosaminidase activity to oxidative stress in diabetes mellitus.
Clinica chimica acta; international journal of clinical chemistry 1999;282(1-2):167-74.
1999: Martin Haluzík; Jara Nedvídková; Jan Skrha
The influence of methylene blue and L-NAME on the development of streptozotocin-induced diabetes in rats.
Sborník lékar̆ský 1999;100(3):213-7.
1999: Martin Prázný; Jan Skrha; Zdenka Límanová; Jirina Hilgertová
The evaluation of thyroid and islet autoantibodies in type 1 diabetes mellitus.
Sborník lékar̆ský 1999;100(3):205-11.
1998: Gustav Sindelka; Jirí Widimský; Martin Prázný; Jirina Hilgertová; Jan Skrha
[The effect of insulin in primary hyperaldosteronism].
Casopís lékar̆ů c̆eských 1998;137(11):338-40.
1998: Jan Skrha; Gustav Sindelka; L Krusina; Jirina Hilgertová; J Páv
[Personal experience with the treatment of organic hyperinsulinism].
Vnitr̆ní lékar̆ství 1998;44(4):217-21.
1998: Jan Skrha; Jindriska Perusicová; Jan Kvasnicka; Jirina Hilgertová
The effect of glycosaminoglycan sulodexide on oxidative stress and fibrinolysis in diabetes mellitus.
Sborník lékar̆ský 1998;99(2):103-9.
1998: Jan Kvasnicka; Jan Skrha; Jindriska Perusicová; Tomás Kvasnicka; Markéta Marková; A Umlaufová; Ladislav Pecen
Haemostasis, cytoadhesive molecules (sE-selectin and sICAM-1) and inflammatory markers in non-insulin dependent diabetes mellitus (NIDDM).
Sborník lékar̆ský 1998;99(2):97-101.
1998: Martin Haluzík; Jara Nedvídková; Jan Skrha
The influence of NO synthase inhibitor and free oxygen radicals scavenger--methylene blue--on streptozotocin-induced diabetes in rats.
Physiological research / Academia Scientiarum Bohemoslovaca 1998;47(5):337-41.
1997: Jindriska Perusicová; Jan Skrha
[The effect of sulodexide, a glycosaminoglycan, on albuminuria in diabetic patients].
Vnitr̆ní lékar̆ství 1997;43(11):748-52.
1997: Jan Skrha; Jindriska Perusicová; P Pont'uch; A Oksa
Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
Diabetes research and clinical practice 1997;38(1):25-31.
1997: Jan Skrha; Gustav Sindelka; Jirina Hilgertová
The effect of fasting and vitamin E on insulin action in obese type 2 diabetes mellitus.
Annals of the New York Academy of Sciences 1997;827():556-60.
1997: Gustav Sindelka; Jan Skrha; Jirina Hilgertová; Vlasta Justová
[The effect of a short-term reducing diet on the effect of insulin in type 2 diabetes mellitus].
Casopís lékar̆ů c̆eských 1997;136(17):530-2.
1996: Jan Skrha; Gustav Sindelka; T Haas; Jirina Hilgertová; V Justová
Comparison of insulin sensitivity in patients with insulinoma and obese Type 2 diabetes mellitus.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1996;28(11):595-8.
1996: Gustav Sindelka; Jan Skrha; Jirina Hilgertová; V Justová
[Early diagnosis of impaired glomerular and renal tubule function in patients with acromegaly].
Casopís lékar̆ů c̆eských 1996;135(20):657-9.
1996: Jan Skrha; Gustav Sindelka; H Matĕjovská; Jirina Hilgertová; V Justová; J Páv
[Personal experience with the diagnosis of organic hyperinsulinism].
Vnitr̆ní lékar̆ství 1996;42(9):635-9.
1996: Jan Skrha; A Hodinár; Jan Kvasnicka; Jirina Hilgertová
Relationship of oxidative stress and fibrinolysis in diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1996;13(9):800-5.
1996: Jindriska Perusicová; Jan Skrha; A Hodinár; A Bernovská; V Cacáková; A Richtrová
[Levels of lactic acid in type II diabetics treated with buformin].
Vnitr̆ní lékar̆ství 1996;42(1):7-11.
1995: Jan Skrha
[Insulin resistance and hyperlipoproteinemia].
Vnitr̆ní lékar̆ství 1995;41(2):105-9.
1995: Jan Skrha; J Páv
Clinical research of glucose metabolism.
Sborník lékar̆ský 1995;96(4):345-7.
1994: Jan Skrha; A Hodinár; Jan Kvasnicka; V Stibor; M Sperl; P Stolba; Jirina Hilgertová
Early changes of serum N-acetyl-beta-glucosaminidase, tissue plasminogen activator and erythrocyte superoxide dismutase in relation to retinopathy in type 1 diabetes mellitus.
Clinica chimica acta; international journal of clinical chemistry 1994;229(1-2):5-14.
1994: Jan Skrha; Gustav Sindelka; T Haas; Jirina Hilgertová; V Justová
[Relation between hypertriacylglycerolemia and the action of insulin in type 2 diabetes mellitus].
Casopís lékar̆ů c̆eských 1994;133(16):496-9.
1994: Gustav Sindelka; Jan Skrha; S Svacina; V Justová; D Wichterle
[The effect of Proglicem in patients with an organic hyperinsulinism syndrome].
Casopís lékar̆ů c̆eských 1994;133(2):53-5.
1993: Jan Skrha; M Sperl; P Stolba; Jirina Hilgertová; V Stibor
[Albuminuria and N-acetyl-beta-glucosaminidase activity in a prospective study of type I diabetics].
Vnitr̆ní lékar̆ství 1993;39(7):699-705.
1993: Jan Skrha; Jirina Hilgertová; V Justová
Insulin action in patients with insulinoma influenced by pharmacological and surgical therapy.
Experimental and clinical endocrinology 1993;101(6):360-4.
1993: Gustav Sindelka; Jan Skrha; V Stibor; P Stolba
Glycosaminoglycans in urine of type 1 diabetic patients.
Sborník lékar̆ský 1993;94(1):77-80.
1991: Jan Skrha; T Haas; M Sperl; V Stibor; P Stolba
A six-year follow-up of the relationship between N-acetyl-beta-glucosaminidase and albuminuria in relation to retinopathy.
Diabetic medicine : a journal of the British Diabetic Association 1991;8(9):817-21.
1991: Jan Skrha; Josef Marek; J Srámková; P Stolba
N-acetyl-beta-glucosaminidase and albuminuria in acromegaly.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1991;23(6):285-7.
1990: Stepan Svacina; Roman Hovorka; Jan Skrha
Computer models of albumin and haemoglobin glycation.
Computer methods and programs in biomedicine 1990;32(3-4):259-63.
1990: Jan Skrha; J Páv; Stepan Svacina; J Srámková; Jirina Hilgertová
Glucose metabolism in a patient with insulinoma complicated by hyperosmolar non-ketotic state.
Diabetic medicine : a journal of the British Diabetic Association 1990;7(4):361-3.
1990: Jan Skrha; I Vacková; Jan Kvasnicka; V Stibor; P Stolba; H Richter; H Hörmann
Plasma free N-terminal fibronectin 30-kDa domain as a marker of endothelial dysfunction in type 1 diabetes mellitus.
European journal of clinical investigation 1990;20(2):171-6.
1990: Stepan Svacina; Roman Hovorka; Jan Skrha; Z Masek
Analysis of glycosylated serum protein changes using a computer model.
Czechoslovak medicine 1990;13(4):168-74.
1989: Jan Skrha; J Päv; Stepan Svacina; J Srámková; Z Masek
[The Biostator in the diagnosis and therapy of organic hyperinsulinism].
Casopís lékar̆ů c̆eských 1989;128(37):1170-4.
1989: Jan Skrha; Jindriska Perusicová; M Sperl; J Bendl; P Stolba
N-acetyl-beta-glucosaminidase and albuminuria in normal and diabetic pregnancies.
Clinica chimica acta; international journal of clinical chemistry 1989;182(3):281-7.
1989: Jan Skrha; Stepan Svacina; J Srámková; J Páv
Use of euglycaemic clamping in evaluation of diazoxide treatment of insulinoma.
European journal of clinical pharmacology 1989;36(2):199-201.
1988: Jan Skrha; Jirina Hilgertová; Stepan Svacina; J Srámková; J Páv
Insulin receptors and glucose homeostasis in type 2 diabetics influenced by acetyl-salicylic acid treatment.
Experimental and clinical endocrinology 1988;92(1):119-22.
1988: Jan Skrha; J Srámková; P Broulík; J Páv
[Glycoregulation in primary hyperparathyroidism].
Sborník lékar̆ský 1988;90(7):200-5.
1988: Jan Skrha; Stepan Svacina; Jirina Hilgertová; J Srámková; Roman Hovorka; Jindriska Perusicová; Z Masek; J Páv
[Acylpyrin and glucose homeostasis in diabetes mellitus].
Casopís lékar̆ů c̆eských 1988;127(5):144-8.
1987: Jan Skrha; Jindriska Perusicová; P Stolba; V Stibor; J Páv
Comparison of N-acetyl-beta-glucosaminidase and albuminuria with clinical finding of microangiopathy in type I diabetes mellitus.
Clinica chimica acta; international journal of clinical chemistry 1987;166(2-3):135-41.
1986: J Kábrt; Z Masek; J Páv; Jan Skrha; A Hodinár
[Treatment of type I diabetics with a combination of Superdep + DEP + NZI and an adjustment of the insulin dosage by means of a Biostator].
Vnitr̆ní lékar̆ství 1986;32(4):373-8.